Takano Hiroyuki
Department of Molecular Cardiovascular Pharmacology, Graduate School of Pharmaceutical Sciences, Chiba University.
Yakugaku Zasshi. 2018;138(6):783-785. doi: 10.1248/yakushi.17-00209-1.
The number of patients with chronic heart failure (CHF) is increasing in Japan. Because there is a shortage of medical professionals to address the demands of an aging society, it is important for CHF patients to receive appropriate treatment from medical professionals in their own neighborhoods. Multidisciplinary care, involving physicians, nurses, pharmacists, care managers, et al., is indispensable for providing safe, appropriate home medical care for CHF patients. In multidisciplinary care, pharmacists play an important role, especially in improving patient adherence to CHF treatment regimens. Pharmacists are also expected to participate actively in the improvement of patients' quality of life and the avoidance of hospital readmission. However, team medicine for CHF treatment is in its nascent stage, and the system for providing multidisciplinary care is still under development. It is important to discuss the present situation and the issues facing multidisciplinary care for CHF treatment. In particular, we need to enhance the significance and role of pharmacists in providing successful multidisciplinary care. In this symposium, I highlight the new role of pharmacists in home medical care for CHF treatment and introduce the pharmaceutical education program of Chiba University.
在日本,慢性心力衰竭(CHF)患者的数量正在增加。由于应对老龄化社会需求的医疗专业人员短缺,CHF患者从所在社区的医疗专业人员那里获得适当治疗非常重要。多学科护理,包括医生、护士、药剂师、护理经理等,对于为CHF患者提供安全、适当的家庭医疗护理是必不可少的。在多学科护理中,药剂师发挥着重要作用,尤其是在提高患者对CHF治疗方案的依从性方面。药剂师还应积极参与改善患者的生活质量和避免再次入院。然而,CHF治疗的团队医疗尚处于起步阶段,提供多学科护理的系统仍在发展中。讨论CHF治疗多学科护理的现状和面临的问题很重要。特别是,我们需要提高药剂师在提供成功的多学科护理中的重要性和作用。在本次研讨会上,我将强调药剂师在CHF治疗家庭医疗护理中的新作用,并介绍千叶大学的药学教育项目。